Danielle Hoo Fatt, MD
Gastroenterology · Fishersville, VANPI 1083031546
Payments from drug & device makers
Across 140 payments — averaging $22.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$362
- Johnson & Johnson$302
- Intercept Pharmaceuticals, Inc.$216
- Takeda Pharmaceuticals U.S.A., Inc.$130
- Seagen Inc.$125
- plus $956 from 14 others
What the payments were for
- Food & beverage$2,99395%
- Education$1735%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $1,076 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $362 |
| Johnson & Johnson | 9 | $302 |
| Intercept Pharmaceuticals, Inc. | 6 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $130 |
| Seagen Inc. | 1 | $125 |
| Intra-sana Laboratories | 1 | $122 |
| 3-d Matrix, Inc. | 1 | $121 |
| Nestle Healthcare Nutrition Inc. | 6 | $117 |
| Gilead | 6 | $106 |
| QOL Medical, LLC | 6 | $81 |
| Pfizer | 4 | $72 |
| Bristol Myers Squibb | 5 | $67 |
| Ferring Pharmaceuticals Inc. | 4 | $64 |
| Redhill Biopharma Inc. | 3 | $60 |
| Evoke Pharma, Inc. | 3 | $44 |
| Curium US LLC | 2 | $34 |
| Vivus LLC | 2 | $34 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCALIVA$133
- ADCETRIS$125
- Reltone 200 Mg$122
- Reltone 400 Mg$122
How this compares
$3,166 in reported general payments places this provider in the 45th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 181 | $2,977 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 35 | $650 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $201 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Fishersville
- Larry ClarkLynchburg$8.5M
- Arun SanyalRichmond$5.5M
- Mitchell ShiffmanNewport News$4.7M
- Jasmohan BajajRichmond$4.4M
- Michael FuchsRichmond$1.9M
- Stephen CaldwellCharlottesville$1.8M
- Nirish ShahRoanoke$1.7M
- Michael RyanNorfolk$1.5M
- Omer KhalidNorth Chesterfield$1.2M
- Binu JohnRichmond$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.